What happens next...? (#2242)
iStock Photo 000013769766

What happens next...? (#2242)

I’m conducting an experiment. In the following article, you’ll find a fictional case study centring on two passions of mine. The first is about product leadership, and the second introduces an insight I’ve gleaned from the natural world of the honeybee. Once you’ve read the case, it would be great if you could comment on “what happens next”. This could be based on your experience, your gut feeling or simply be humorous - whatever takes your fancy!

Background

Rainbow Pharma is a global pharmaceutical company. They recently announced plans to spin off their vaccine research division, VioVac. This move will allow VioVac to address one of the key challenges in modern vaccine development - “reverse vaccinology”, which uses computer-based analytics to assess a pathogen’s genetic information to accelerate the understanding of pathogens and their antigens. This research has become even more pressing following the Covid-19 global pandemic.

The Swarming Instinct

Honey bees are social insects, and the honey bee colony is an organism in its own right. The colony reproduces itself by swarming by splitting itself in two. We still aren’t exactly sure why honeybees swarm. It seems to be due to a combination of factors, including the colony, becoming overcrowded, the age and virility of the queen, and some even say the phase of the moon!

Swarming normally happens between April to June in the Northern Hemisphere. It’s a risky time for the colony as the swarm needs to find a new home, and the bees left behind need to produce a new queen, which needs to get mated. And all this needs to happen before the winter sets in; otherwise, either or both colonies (old and new) will likely die off.

Three Candidates for CEO of VioVac

There are three possible internal candidates for the new CEO of Vacofin. They are:

  • Professor Lee Purple - Has overseen the development of the vaccine in his lab. Understands the most about the product's capabilities and potential for development. He’s due to retire in 3 years' time but would be a safe pair of hands.
  • David Blue - An ambitious salesman who has led Rainbow Pharma’s Global Sales team for the past ten years and knows the customer base inside-out.
  • Vanessa Orange - Most recently acted as Vice President of Finance for Rainbow Pharma and created the business case for the spin-out. She has a real handle on the numbers and has said she’ll resign if she doesn’t get the job.

Please comment below on your ideas for "What Happens Next?"

Marina B.

Follow the best architectural practices and think in various ways: Enterprise Architect and Manager, Solution Architect, Cloud Architect, and devoted mom.

2 年

They decide to work together, Blue as a CEO , because everything needs to start with customer in mind, Purple as CTO , because technology is his forte and Orange as CFO…

回复
Graham Berrisford

Director and Principal Tutor, Avancier Limited

2 年

At a three-way meeting, Vanessa (to be CEO) and Lee persuade David to be CMO. David and Vanessa persuade Lee to be CTO with a position on the board of governors (in future if not now)..

Nick Drage

A fractional cyber security strategist using game based methods to enhance your decision making.

2 年

Interesting idea - for me because I advocate for using analogies to problem solve, but paying attention when they break, I think that can be a useful way to illustrate new solutions. I.E. in this case, the bees need to develop a queen from their existing swarm, they can't talk to a queen recruiter, or put an advert on the local... er... tree? But in the business case, there's no need for Viovac to recruit internally, and to me none of the candidates seem suitable - Purple and Blue are obviously very well suited to their current positions so why take from their current work? As for Orange, an employee driven policy for promotions is not only a bad idea in general, but once you've allowed it work what else will Orange demand? So in summary I'd look elsewhere for the CEO, , and I really like the clash of two ideas as a way to think about the problem. ( and I'm assuming this isn't a "disguised scenario", and we're not making a decision for one of your customers... ?? )

Jill Chang

Enterprise Architect | Integration Advisor | Change Facilitator | Founder of How 2 Integrate

2 年

If ViVac is at its early stage of product development in a growing market, I will vote for Blue. If the value of VioVac lies in its research capability or patents, I may go Purple. If VioVac needs a turnaround, I may go with Orange.

Tim Jalland

Estate Manager: Leader / Project Manager / Corporate Communicator / Corporate Collaborator / Security Advisor / HR Manager / Relationship Builder / Wildlife Manager

2 年

Can Orange take Blue with her?

要查看或添加评论,请登录

社区洞察

其他会员也浏览了